Literature DB >> 3924164

Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease.

J W Dean, P B Fowler.   

Abstract

Thyroid function tests were performed and thyroid antibodies and serum cholesterol concentrations measured in 12 women aged 60 years or under with severe coronary artery disease proved by coronary angiography. This group was compared with 11 women with normal coronary angiography. Ten out of the 12 women with coronary artery disease had an exaggerated response of thyroid stimulating hormone to thyrotrophin releasing hormone compared with two out of 11 controls (p less than 0.008). The mean serum cholesterol concentration was significantly higher in those with coronary artery disease than in the controls. Thyroid antibodies were present in four of those with coronary artery disease and one of the controls. There was no difference in the risk factors for coronary artery disease between the two groups except for cigarette smoking. Eleven out of 12 in the coronary artery disease group smoked cigarettes compared with four out of 11 in the control group (p less than 0.01). Minimal impairment of thyroid function is an important risk factor for coronary artery disease in women.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924164      PMCID: PMC1415754          DOI: 10.1136/bmj.290.6481.1555

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Studies on organ specificity. IV. Production of rabbit thyroid antibodies in the rabbit.

Authors:  E WITEBSKY; N R ROSE
Journal:  J Immunol       Date:  1956-06       Impact factor: 5.422

2.  Thyrotrophin-releasing hormone as a thyroid-function test.

Authors:  B J Ormston; R J Cryer; R Garry; G M Besser; R Hall
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

3.  Progressive supranuclear palsy and normal-pressure hydrocephalus.

Authors:  M A Morariu
Journal:  Neurology       Date:  1979-11       Impact factor: 9.910

4.  Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents.

Authors:  R D Rafal; R J Grimm
Journal:  Neurology       Date:  1981-12       Impact factor: 9.910

5.  The 'subcortical dementia' of progressive supranuclear palsy.

Authors:  M L Albert; R G Feldman; A L Willis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-02       Impact factor: 10.154

6.  New form of familial Parkinson-dementia syndrome: clinical and pathologic findings.

Authors:  M Mata; K Dorovini-Zis; M Wilson; A B Young
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

7.  Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies.

Authors:  P A Bastenie; L Vanhaelst; J Golstein; P Smets
Journal:  Lancet       Date:  1977-07-23       Impact factor: 79.321

8.  Progressive supranuclear palsy.

Authors:  J C Steele
Journal:  Brain       Date:  1972       Impact factor: 13.501

  8 in total
  11 in total

1.  Journalology--or what editors do.

Authors:  J Smith
Journal:  BMJ       Date:  1990-10-03

2.  Thyroxine replacement treatment and osteoporosis.

Authors: 
Journal:  BMJ       Date:  1990-04-21

3.  Use of check lists in assessing the statistical content of medical studies.

Authors:  M J Gardner; D Machin; M J Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

4.  Diabetologia 1965-1985--portrait of a journal.

Authors:  M Berger
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

Review 5.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

6.  Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?

Authors:  D Pallas; D A Koutras; P Adamopoulos; P Marafelia; A Souvatzoglou; G Piperingos; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

7.  Thyroid function is associated with presence and severity of coronary atherosclerosis.

Authors:  J Auer; R Berent; T Weber; E Lassnig; B Eber
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

8.  Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease.

Authors:  Ahmet Sert; Ozgur Pirgon; Ebru Aypar; Hakan Yilmaz; Dursun Odabas
Journal:  Pediatr Cardiol       Date:  2013-01-24       Impact factor: 1.655

9.  Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment.

Authors:  F Monzani; P Del Guerra; N Caraccio; C A Pruneti; E Pucci; M Luisi; L Baschieri
Journal:  Clin Investig       Date:  1993-05

10.  Selenium status and cardiovascular risk profile in healthy adult Saudi males.

Authors:  Eman M Alissa; Waqar H Ahmed; Nabeel Al-ama; Gordon A A Ferns
Journal:  Molecules       Date:  2008-12-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.